Vanguard Group Inc 2seventy Bio, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,772,232 shares of TSVT stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,772,232
Previous 3,629,121 3.94%
Holding current value
$11.7 Million
Previous $14 Million 27.43%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$3.85 - $5.05 $550,977 - $722,710
143,111 Added 3.94%
3,772,232 $17.8 Million
Q2 2024

Aug 13, 2024
SELL
$3.6 - $5.79 $369,208 - $593,810
-102,558 Reduced 2.75%
3,629,121 $14 Million
Q1 2024

May 10, 2024
SELL
$3.09 - $6.0 $785,141 - $1.52 Million
-254,091 Reduced 6.37%
3,731,679 $20 Million
Q4 2023

Feb 14, 2024
BUY
$1.57 - $4.58 $395,472 - $1.15 Million
251,893 Added 6.75%
3,985,770 $17 Million
Q3 2023

Nov 14, 2023
BUY
$3.14 - $11.2 $804,477 - $2.87 Million
256,203 Added 7.37%
3,733,877 $14.6 Million
Q2 2023

Aug 14, 2023
BUY
$8.45 - $12.48 $4.85 Million - $7.16 Million
573,640 Added 19.75%
3,477,674 $35.2 Million
Q1 2023

May 15, 2023
BUY
$9.21 - $14.98 $4.6 Million - $7.49 Million
499,805 Added 20.79%
2,904,034 $29.6 Million
Q4 2022

Feb 10, 2023
BUY
$8.57 - $17.0 $413,896 - $821,032
48,296 Added 2.05%
2,404,229 $22.5 Million
Q3 2022

Nov 14, 2022
BUY
$12.56 - $17.54 $324,676 - $453,409
25,850 Added 1.11%
2,355,933 $34.3 Million
Q2 2022

Aug 12, 2022
BUY
$10.55 - $18.81 $10 Million - $17.9 Million
949,757 Added 68.81%
2,330,083 $30.8 Million
Q1 2022

May 13, 2022
SELL
$11.67 - $26.72 $5.6 Million - $12.8 Million
-479,623 Reduced 25.79%
1,380,326 $23.5 Million
Q4 2021

Feb 14, 2022
BUY
$13.77 - $42.56 $25.6 Million - $79.2 Million
1,859,949 New
1,859,949 $47.7 Million

Others Institutions Holding TSVT

# of Institutions
126
Shares Held
45.6M
Call Options Held
122K
Put Options Held
19.8K
View Full List

About 2seventy bio, Inc.

TSVT Quotes by TradingView
  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $118M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email